Philippe Lesprit

2.9k total citations · 1 hit paper
60 papers, 1.8k citations indexed

About

Philippe Lesprit is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Philippe Lesprit has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Infectious Diseases and 14 papers in Surgery. Recurrent topics in Philippe Lesprit's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (9 papers). Philippe Lesprit is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Pneumonia and Respiratory Infections (9 papers). Philippe Lesprit collaborates with scholars based in France, United States and Belgium. Philippe Lesprit's co-authors include Patrick Legrand, Christian Brun‐Buisson, Bertrand Godeau, Jean‐Michel Molina, François‐Jérôme Authier, Romain K. Gherardi, J.P. Bru, Keyvan Razazi, Lennie Derde and A. Therby and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Philippe Lesprit

58 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

2014 315 citations Louis Bernard, Aurélien Dinh et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Philippe Lesprit	575	525	483	306	211	60	1.8k
Chen‐Hsiang Lee	790 1.4×	833 1.6×	777 1.6×	514 1.7×	252 1.2×	145	2.5k
Eva Leitner	412 0.7×	261 0.5×	414 0.9×	538 1.8×	111 0.5×	81	1.9k
C. Ruef	600 1.0×	229 0.4×	491 1.0×	215 0.7×	119 0.6×	49	1.6k
Elpis Mantadakis	919 1.6×	438 0.8×	492 1.0×	210 0.7×	264 1.3×	151	2.8k
J. A. Martínez	768 1.3×	400 0.8×	794 1.6×	231 0.8×	123 0.6×	30	2.1k
Denis Spelman	800 1.4×	478 0.9×	793 1.6×	665 2.2×	152 0.7×	63	2.3k
Jang Wook Sohn	991 1.7×	312 0.6×	781 1.6×	323 1.1×	99 0.5×	140	2.3k
Bilgül Mete	487 0.8×	177 0.3×	417 0.9×	333 1.1×	117 0.6×	117	1.4k
E Soriano	770 1.3×	306 0.6×	641 1.3×	190 0.6×	85 0.4×	55	1.5k
Elizabeth Sheridan	557 1.0×	380 0.7×	354 0.7×	211 0.7×	266 1.3×	43	1.8k

Countries citing papers authored by Philippe Lesprit

Since Specialization

Citations

This map shows the geographic impact of Philippe Lesprit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lesprit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lesprit more than expected).

Fields of papers citing papers by Philippe Lesprit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lesprit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lesprit. The network helps show where Philippe Lesprit may publish in the future.

Co-authorship network of co-authors of Philippe Lesprit

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lesprit. A scholar is included among the top collaborators of Philippe Lesprit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lesprit. Philippe Lesprit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stahl, J.‐P., Bernard Castan, É. Bonnet, et al.. (2022). Utilization of macrolides. State of the art 2022 Spilf and GPIP. Infectious Diseases Now. 52(5). 252–266.

Cahen, P, et al.. (2022). Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection. Infectious Diseases Now. 52(8). 421–425. 7 indexed citations

Gauzit, R., Bernard Castan, É. Bonnet, et al.. (2021). Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 51(2). 114–139. 20 indexed citations

Vallée, Alexandre, Brigitte Bonan, Philippe Lesprit, et al.. (2021). Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign. Public Health. 196. 135–137. 10 indexed citations

Lesprit, Philippe, et al.. (2021). A strain uncoloured by Gram staining in a pleural fluid. Clinical Microbiology and Infection. 28(7). 973–974. 3 indexed citations

Farfour, Éric, Philippe Lesprit, Benoît Visseaux, et al.. (2020). The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?. European Journal of Clinical Microbiology & Infectious Diseases. 39(10). 1997–2000. 47 indexed citations

Diamantis, S., et al.. (2020). Home intravenous antibiotherapy and the proper use of elastomeric pumps: Systematic review of the literature and proposals for improved use. Infectious Diseases Now. 51(1). 39–49. 27 indexed citations

Launay‐Vacher, Vincent, Alexandre Bleibtreu, Perrine Bortolotti, et al.. (2019). Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Médecine et Maladies Infectieuses. 50(4). 323–331. 20 indexed citations

Pilmis, B., et al.. (2019). Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 38(8). 1457–1461. 38 indexed citations

10.

Bru, J.P., S. Alfandari, Alexandre Bleibtreu, et al.. (2019). Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Médecine et Maladies Infectieuses. 50(4). 313–315. 2 indexed citations

11.

Farfour, Éric, Philippe Lesprit, Erwan Fourn, et al.. (2018). Acute hepatitis A breakthrough in MSM in Paris area. AIDS. 32(4). 531–532. 6 indexed citations

12.

Bernard, Louis, Aurélien Dinh, Idir Ghout, et al.. (2014). Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. The Lancet. 385(9971). 875–882. 315 indexed citations breakdown →

13.

Landelle, Caroline, Patrick Legrand, Philippe Lesprit, et al.. (2013). Protracted outbreak of multidrug-resistant Acinetobacter baumannii after intercontinental transfer of colonized patients. Archive ouverte UNIGE (University of Geneva). 2 indexed citations

14.

Lesprit, Philippe, et al.. (2010). New Bacteriological Patterns in Primary Infected Aorto-iliac Aneurysms: A Single-centre Experience. European Journal of Vascular and Endovascular Surgery. 40(5). 582–588. 48 indexed citations

15.

Cattoir, Vincent, et al.. (2010). Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. Clinical Microbiology and Infection. 17(3). 425–431. 23 indexed citations

16.

Zahar, J.-R., et al.. (2005). Severe soft tissue infections of the extremities in patients admitted to an intensive care unit. Clinical Microbiology and Infection. 11(1). 79–82. 23 indexed citations

17.

Lesprit, Philippe, François Faurisson, Olivier Join‐Lambert, et al.. (2003). Role of the Quorum-sensing System in Experimental Pneumonia due to Pseudomonas aeruginosa in Rats. American Journal of Respiratory and Critical Care Medicine. 167(11). 1478–1482. 58 indexed citations

18.

Lesprit, Philippe, Bertrand Godeau, François‐Jérôme Authier, et al.. (1998). Pulmonary Hypertension in POEMS Syndrome: A New Feature Mediated by Cytokines. American Journal of Respiratory and Critical Care Medicine. 157(3). 907–911. 112 indexed citations

19.

Lesprit, Philippe, François‐Jérôme Authier, Romain K. Gherardi, et al.. (1996). Acute Arterial Obliteration: A New Feature of the POEMS Syndrome?. Medicine. 75(4). 226–232. 62 indexed citations

20.

Lesprit, Philippe, Philippe Bierling, A Schaeffer, et al.. (1996). Prolonged Remission of SLE-associated Polyradiculoneuropathy after a Single Course of Intravenous Immunoglobulin. Scandinavian Journal of Rheumatology. 25(3). 177–179. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact